概括
长期使用雌激素 (≥3.5年) 显著增加子宫内膜癌的风险,特别是在早期的疾病. 短期使用没有显示任何癌症阶段或类型的风险增加.
科学领域:
- 妇科瘤学 妇科瘤学
- 内分泌学 在内分泌学.
- 癌症流行病学 癌症流行病学
背景情况:
- 雌激素疗法广泛用于更年期症状.
- 以前的研究表明,雌激素使用与子宫内膜癌之间存在联系.
- 雌激素使用的持续时间,剂量和模式与特定的子宫内膜癌特征之间的关系需要进一步澄清.
研究的目的:
- 研究雌激素处方模式与子宫内膜癌的临床阶段和病理特征之间的关联.
- 为了确定雌激素的使用时间和剂量是否会影响不同阶段和组织学类型的子宫内膜癌风险.
主要方法:
- 一项病例对照研究,将256例子宫内膜癌病例与321名社区对照对象进行比较.
- 对雌激素使用持续时间 (不到3.5年与3.5年或更长时间),剂量 (高与低) 和给药模式 (连续与循环) 的分析.
- 根据临床阶段,组织学等级和肌肉膜侵袭的深度对风险的分层.
主要成果:
- 短期使用雌激素 (<3.5年) 没有提高任何阶段,等级,类型或侵袭程度的子宫内膜癌风险.
- 长期使用雌激素 (≥3.5年) 显著增加了早期癌症的相对风险 (5.2至7.6) (I.A阶段,1级,受子宫内膜限制).
- 高剂量和低剂量雌激素制剂在长期使用时都显示出增加的风险;晚期癌症的风险只增加了很小的风险,除了持续使用导致晚期癌症风险增加.
结论:
- 长期使用雌激素治疗与早期子宫内膜癌的风险显著增加有关.
- 长期使用雌激素会极小地增加晚期子宫内膜癌的风险,而持续使用则会带来更高的风险.
- 这些发现凸显了在评估子宫内膜癌风险时考虑雌激素使用时间和施用模式的重要性.
相关概念视频
Oogenesis
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
Gonadal and Placental Hormones
The gonads, namely the testes in males and the ovaries in females, are pivotal in producing gonadal hormones that orchestrate the intricate processes of sexual development and reproduction.
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair growth — and...
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair growth — and...
Hormonal Regulation of the Menstrual Cycle
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Ovarian Cycle
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle length...
Hormonal Control of the Ovarian Cycle
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Menopause
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...


